Astellas hires senior VP from rival Takeda

pharmafile | August 15, 2013 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |  Astellas, Takeda, oncology 

Astellas has appointed Claire Thom from fellow Japanese firm Takeda to be senior vice president of its global oncology development.

Thom will report to chief medical officer Sef Kurstjens at Astellas, and will replace Dr Wayne Klohs who recently retired.

“We ‘re thrilled that Claire is joining our experienced oncology team at Astellas,” said Kurstjens. “We believe that her unique background and varied experience, along with her approach to leadership and management will support our mission to become a global category leader in oncology. “

Thom has more than 24 years of experience in the pharma industry across a wide range of functional areas including drug development, new product planning and marketing.

Most recently she served as senior VP Portfolio Management, Drug Development Management and Strategic Business Operations at Millennium: The Takeda Oncology Company.